Medidata Solutions, Inc. (NASDAQ:MDSO) shareholders just endured a pretty tough week. Though shares were up 300% over the last three years, they lost about one-quarter of that value last Tuesday alone.
The company focuses on providing cloud solutions for drug companies. Specifically, its software helps pharmaceutical companies collect, analyze, and manage information that goes hand in hand with drug trials. Business has been growing briskly, but earnings that came in well below Wall Street's expectations caused last week's precipitous drop.
But were things really that bad? In the video below, The Motley Fool's Brian Stoffel digs into the three most important numbers for investors to keep their eyes on moving forward and what he thinks of shares right now.
Brian Stoffel owns shares of Medidata Solutions. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Earnings Are Causing Medidata Solutions Shares to Drop 10% Today
Investors may want to look beyond the top-line miss and focus on future growth.
Why Medidata Solutions Inc. Shares Soared Higher Today
Robust revenue and EPS helped propel Medidata Solutions Inc. shares higher today.
Investing in Socially Responsible Companies: Medidata Solutions Inc.
Some socially responsible companies can make you wealthy.